A52.05 Other cerebrovascular syphilis
The ICD-10-CM code for Other cerebrovascular syphilis is A52.05 (FY2026). It is a billable, claim-ready diagnosis code.
Classification
- Section
- A50-A64: Infections with a predominantly sexual mode of transmission (A50-A64)
- Category A52
- 34 codes (30 billable)
- FY2026 Status
- Stable since FY2024
Also Known As
ICD-10-CM Alphabetic Index entries that lead to A52.05:
- Neurosyphilis (arrested) (early) (gumma) (late) (latent) (recurrent) (relapse) › aneurysm (cerebral)
- Syphilis, syphilitic (acquired) › cerebrovascular
- Angiopathia, angiopathy › retinae syphilitica
- Neurosyphilis (arrested) (early) (gumma) (late) (latent) (recurrent) (relapse) › thrombosis (cerebral)
- Neurosyphilis (arrested) (early) (gumma) (late) (latent) (recurrent) (relapse) › hemorrhagic
- Neurosyphilis (arrested) (early) (gumma) (late) (latent) (recurrent) (relapse) › vascular (cerebral) NEC
- Aneurysm (anastomotic) (artery) (cirsoid) (diffuse) (false) (fusiform) (multiple) (saccular) › central nervous system, syphilitic
- Aneurysm (anastomotic) (artery) (cirsoid) (diffuse) (false) (fusiform) (multiple) (saccular) › brain › syphilitic (hemorrhage)
Inclusion Terms
- Syphilitic cerebral aneurysm (ruptured) (non-ruptured)
- Syphilitic cerebral thrombosis
U.S. Hospital Utilization
A52.05 appeared in too few sampled U.S. inpatient stays in 2023 to report a national estimate (AHRQ suppresses counts of 10 or fewer) — a rare inpatient diagnosis.
Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.
Official Coding Guidelines
HIV Infections (TOC entry)a. Human Immunodeficiency Virus (HIV) Infections .............................................................. 19
Infectious agents causing diseases in other chapters (TOC)b. Infectious agents as the cause of diseases classified to other chapters ................................. 22
Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026